Boldrini Renata, De Pasquale Maria Debora, Melaiu Ombretta, Chierici Marco, Jurman Giuseppe, Benedetti Maria Chiara, Salfi Nunzio C, Castellano Aurora, Collini Paola, Furlanello Cesare, Pistoia Vito, Cifaldi Loredana, Terenziani Monica, Fruci Doriana
Department of Pathology, IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy.
Department of Oncohaematology, IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy.
Oncoimmunology. 2018 Dec 13;8(2):e1542245. doi: 10.1080/2162402X.2018.1542245. eCollection 2019.
Although pediatric malignant extracranial germ-cell tumors (meGCTs) are among the most chemosensitive solid tumors, a group of patients relapse and die of disease. To identify new markers predicting clinical outcome, we examined the prognostic relevance of tumor-infiltrating T lymphocytes (TILs) and the expression of PD-1 and PD-L1 in a cohort of pediatric meGCTs by immunohistochemistry. MeGCTs were variously infiltrated by T cell-subtypes according to the tumor subtype, tumor location and age at diagnosis. We distinguished three different phenotypes: i) tumors not infiltrated by T cells (immature teratomas and half of the yolk sac tumors), ii) tumors highly infiltrated by CD8 T cells expressing PD-1, which identifies activated tumor-reactive T cells (seminomas and dysgerminomas), iii) tumors highly infiltrated by CD8 T cells within an immunosuppressive tumor microenvironment characterized by CD4FOXP3 Treg cells and PD-L1-expressing tumor cells (embryonal carcinomas, choriocarcinomas and the remaining yolk sac tumors). Tumor subtypes belonging mixed meGCTs were variously infiltrated, suggesting the coexistence of multiple immune microenvironments either facilitating or precluding the entry of T cells. These findings support the hypothesis that TILs influence the development of meGCTs and might be of clinical relevance to improve risk stratification and the treatment of pediatric patients.
尽管小儿恶性颅外生殖细胞肿瘤(meGCTs)是对化疗最敏感的实体瘤之一,但仍有一部分患者会复发并死于该疾病。为了确定预测临床结局的新标志物,我们通过免疫组织化学检查了小儿meGCTs队列中肿瘤浸润性T淋巴细胞(TILs)的预后相关性以及PD-1和PD-L1的表达。根据肿瘤亚型、肿瘤位置和诊断时的年龄,meGCTs被不同的T细胞亚型浸润。我们区分出三种不同的表型:i)未被T细胞浸润的肿瘤(未成熟畸胎瘤和一半的卵黄囊瘤),ii)被表达PD-1的CD8 T细胞高度浸润的肿瘤,这可识别活化的肿瘤反应性T细胞(精原细胞瘤和无性细胞瘤),iii)在以CD4FOXP3调节性T细胞(Treg细胞)和表达PD-L1的肿瘤细胞为特征的免疫抑制性肿瘤微环境中被CD8 T细胞高度浸润的肿瘤(胚胎癌、绒毛膜癌和其余的卵黄囊瘤)。属于混合性meGCTs的肿瘤亚型有不同程度的浸润,这表明存在多种免疫微环境,它们要么促进要么阻止T细胞的进入。这些发现支持了TILs影响meGCTs发展的假设,并且可能与改善小儿患者的风险分层和治疗具有临床相关性。